BIO 2019 - Tagged with Interest Area>Gene/Cell Therapy

bio2018-mybio-sessionicon-companypres

Belgium - Global Innovation Hub

Theater 4

Mrs. Sylvie MEEKERSLife Sciences Advisor atBio.be/essenscia

Business Development and Finance

Building a Winning Team for Biotech Business Success – Lessons You Can Learn from Industry Veterans and Former NFL Player Turned Broadcaster Solomon Wilcots

107AB, Level 100

Solomon WilcotsSports broadcaster and Sports-Health Alliance Leader atSirius XM Inc.; Russo Partners, LLC; Sky Sports UK Raza BokhariCo-Chairman and Interim CEO atFSD Pharma Mei Mei HuChief Executive Officer atUnited Neuroscience Ltd. William NewellChief Executive Officer and Director atSutro Biopharma Inc. Gil Van BokkelenChairman and CEO atAthersys

Business Development and Finance

Get Relevant or Go Home: Shedding Light on Oncology R&D Sums

107AB, Level 100

Ms. Lisa UrquhartEditor, Vantage atEvaluate Ltd Curtis HechtChief Business Officer atCalithera Biosciences Dr. Paul JuniewiczSr. Director, Oncology Search & Evaluation atTakeda Debi WatsonVice President, Business Development and Licensing atJohnson & Johnson Innovation, Janssen Business Development

bio2018-mybio-sessionicon-companypres

Kalos Therapeutics Inc Start-Up Stadium

Hall E, Booth 3971, Level 200

Mr. George Colberg, Jr.CEO Co-founder atKalos Therapeutics Inc

Business Development and Finance

Leveraging America’s Seed Fund (SBIR/STTR) to Accelerate Life Sciences Technology Development and Secure Follow-On Investments

109AB, Level 100

Ashim SubedeeProgram Director atNCI Small Business Innovation Research (SBIR) Development Center Dr. Matthew PortnoyProgram Manager, NIH SBIR/STTR Program atNational Institutes of Health Michal PremingerHead, J&J Innovation, East North America atJohnson & Johnson Innovation Allen ReitzCEO atFox Chase Chemical Diversity Center, Inc. Stephanie StehmanPrincipal atOsage University Partners

nextgenerationicon

Next Generation Biotherapeutics

Opportunities and Challenges of Cell and Gene Therapy Development

105AB, Level 100

Niki GalloSenior Consultant atHalloran Consulting Group Kailash BholDirector, Preclinical Development atAstellas Institute of Regenerative Medicine Dr. Mitchell FinerExecutive Partner atMPM Capital Dr. Michael PagliaSr. Vice President, CMC Operations atElevatebio

bio2018super_sessions

What’s Next: The Landscape of Innovation in 2019 and Beyond

103ABC, Level 100

Barbara DaltonVice President, Worldwide Business Development atPfizer Inc. Dr. David DonabedianCo-founder, CEO and Director atAxial Biotherapeutics Chris GarabedianChairman and CEO atXontogeny, LLC Curt HerbertsChief Financial Officer and Chief Business Officer atSenti Biosciences, Inc. David ThomasVice President, Industry Research atBiotechnology Innovation Organization Ben ThornerSenior Vice President & Head, MRL Business Development & Licensing atMerck & Co., Inc. Sam UlinManaging Director atClearView Healthcare Partners